| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 16 | +75.00% | -2.49% | +0.77% | -3.26% | -4.56% | — |
| 14d | 16 | +62.50% | -2.39% | +0.56% | -2.95% | -4.72% | — |
| 30d | 16 | +62.50% | -1.14% | -1.41% | -0.21% | -7.90% | — |
| 60d | 16 | +68.75% | -5.08% | +1.70% | -6.79% | -17.17% | — |
| 90d | 16(3 pending) | +76.92% | -12.65% | +1.86% | -14.59% | -14.13% | — |
| 180d | 16(10 pending) | +66.67% | -22.24% | +4.34% | -26.58% | -42.94% | — |
| 1y | 16(13 pending) | +100.00% | -28.28% | +13.19% | -41.48% | -40.24% | — |
| 2y | 16(16 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 2,501 | $16.24 | $40.6K | 135,202 | Jul 1, 2026 | Jul 2, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 4,183 | — | — | 34,297 | Jul 1, 2026 | Jul 2, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,852 | $15.67 | $91.7K | 137,703 | Jul 1, 2026 | Jul 2, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 4,183 | $1.01 | $4.2K | 143,555 | Jul 1, 2026 | Jul 2, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 28,826 | $1.01 | $29.1K | 168,198 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 28,826 | $16.04 | $462.3K | 139,372 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 28,826 | — | — | 38,480 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 4,170 | $13.16 | $54.9K | 139,372 | Jun 1, 2026 | Jun 1, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 300 | $13.84 | $4.2K | 143,542 | May 1, 2026 | May 1, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 3,870 | $13.06 | $50.5K | 143,842 | May 1, 2026 | May 1, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 4,170 | $13.43 | $56.0K | 147,712 | Apr 6, 2026 | Apr 6, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 4,170 | $15.01 | $62.6K | 151,882 | Mar 2, 2026 | Mar 2, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 3,824 | $16.01 | $61.2K | 156,052 | Feb 25, 2026 | Feb 26, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 3,824 | $1.01 | $3.9K | 159,876 | Feb 25, 2026 | Feb 26, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 3,824 | — | — | 67,306 | Feb 25, 2026 | Feb 26, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 4,300 | $1.01 | $4.3K | 160,352 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 4,300 | $16.03 | $68.9K | 156,052 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 4,300 | — | — | 71,130 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 100 | $1.01 | $101 | 156,152 | Feb 19, 2026 | Feb 20, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 100 | $16.00 | $1.6K | 156,052 | Feb 19, 2026 | Feb 20, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 100 | — | — | 75,430 | Feb 19, 2026 | Feb 20, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 400 | — | — | 75,530 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 400 | $1.01 | $404 | 156,452 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 400 | $16.00 | $6.4K | 156,052 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 3,000 | $14.82 | $44.5K | 157,222 | Feb 3, 2026 | Feb 5, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,170 | $15.25 | $17.8K | 156,052 | Feb 3, 2026 | Feb 5, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,500 | — | — | 6,500 | Jan 30, 2026 | Jan 30, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 160,000 | — | — | 160,000 | Jan 30, 2026 | Jan 30, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 3,670 | $10.35 | $38.0K | 160,722 | Jan 5, 2026 | Jan 6, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 500 | $11.13 | $5.6K | 160,222 | Jan 5, 2026 | Jan 6, 2026 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 4,170 | $12.23 | $51.0K | 164,392 | Dec 23, 2025 | Dec 30, 2025 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 110,000 | — | — | 110,000 | Jan 31, 2025 | Jan 31, 2025 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,700 | — | — | 3,700 | Jan 31, 2025 | Jan 31, 2025 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,010 | $16.02 | $16.2K | 168,562 | Nov 25, 2024 | Nov 27, 2024 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 6,091 | $16.37 | $99.7K | 169,671 | Nov 18, 2024 | Nov 20, 2024 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 99 | $17.05 | $1.7K | 169,572 | Nov 18, 2024 | Nov 20, 2024 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | May 24, 2024 | May 29, 2024 ↗ | View → |
| CTNM CONTINEUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,700 | — | — | 3,700 | May 24, 2024 | May 29, 2024 ↗ | View → |